FDAClass II · Drug · Recall D-0829-2026 · Recalled September 9, 2026

Broadway Joe's Pain Cream recall — Lexia LLC

Agency report date: September 9, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named: Broadway Joe's Pain Cream
Company / brand: Lexia
Lot / serial / date codes: Lot #: T1110, Exp: 1/7/2027; T1111, Exp: 1/9/2027; T1112, Exp: 1/16/2027; T1113, Exp: 1/17/2027; T1114, Exp: 1/17/2027
Distribution: Distributed in the state of Colorado (US).

Agency product description and boundaries

Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil 2000mg),4 oz-jar, Produced for Broadway Joe's, Franklin, TN, 37067, NDC 83088-8120-6; UPC 8 50041 64004 4

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: CGMP Deviations: Potential contamination of raw material

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Broadway Joe's Pain Cream recall status

3. Open the official notice or contact

View the official FDA enforcement record (openFDA) ↗

Official recall ID: D-0829-2026
Brand: All Lexia recalls
Classification: Class II
Units affected: 1,200 4 oz-Jar
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Affected products

Broadway Joe's Pain Cream recall status

Companies & origin

Recalling firm location: Franklin, TN, United States
Firm address: 367 Riverside Dr Ste 100, N/A, 37064-8977

Identifying details (verbatim from the notice)

Product codes / lots: Lot #: T1110, Exp: 1/7/2027; T1111, Exp: 1/9/2027; T1112, Exp: 1/16/2027; T1113, Exp: 1/17/2027; T1114, Exp: 1/17/2027
Distribution: Distributed in the state of Colorado (US).
Firm notified the public via: Letter
FDA event ID: 99751
Recall initiated: August 21, 2026
FDA classified: September 2, 2026
FDA report date: September 9, 2026

Other drug recalls from around the same time

Epinephrine Injection recall — American Regent, Inc.FDA · September 16, 2026
Dextrose Injection recall — Baxter Healthcare CorporationFDA · September 16, 2026
Glutathione 200 mg/mL recall — OPTIMAL BALANCE PHARMACYFDA · September 9, 2026
0 recall — Baxter Healthcare CorporationFDA · September 9, 2026
Lactated Ringer's Injection USP recall — B BRAUN MEDICAL INCFDA · September 2, 2026

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 12:00 PM UTC. Record retrieved October 22, 2026 at 12:00 PM UTC.

Report a data error on this page